MacroGenics, Inc. MGNX 深 滬
已收盤 05-08 16:00:00 美东时间
3.00
+0.060
+2.04%
華盛通- 最 高3.095
- 今 開2.96
- 成交量 81.42万股
- 最 低 2.90
- 昨 收 2.94
- 總市值 1.91亿
- 52周最高 3.88
- 市盈率 靜 --
- 換手率 1.28%
- 52周最低 1.185
- 委 比 24.44%
- 總股本 6356.01万
- 歷史最高 41.00
- 量 比 1.19
- 振 幅 6.63%
- 歷史最低 0.9897
- 每 手 1
- 風險率 0.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MacroGenics Enters Into Expanded Royalty Purchase Agreement With Sagard In Exchange For Capped Royalty Interest On Future Global Net Sales Of ZYNYZ
MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that it entered into an expanded
05-04 19:33
美股大行评级 | 大摩上调Lumentum目标价从595美元升至710美元；康宁、道富银行、Ally Financial获多家机构上调目标价
今日重点评级关注：Canaccord Genuity：维持Vertical Aerospace"买入"评级，目标价从9.5美元升至10.5美元；Canaccord Genuity：维持AtaiBeckley Inc."买入"评级，目标价从14美元升至15美元
04-21 11:25
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $6
Barclays analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Overweight and raises the price target from $4 to $6.
04-20 21:49
MacroGenics Says FDA Removes Partial Clinical Hold On Phase 2 LINNET Study Of Lorigerlimab, Investigational, Bispecific DART Molecule That Targets PD-1 And CTLA-4
• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers• On track to provide mid-2026 program update ROCKVILLE, MD, April 08, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a
04-09 04:32
美股牛股 | VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%
VYGR飙升21%，Q4亏损收窄及销售额超预期；Figure大涨超20%，进军汽车贷款市场获华尔街唱多；Stagwell涨逾17%，引入AppLovin先进的移动广告平台>>
03-11 16:04
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
Barclays Maintains Overweight on Macrogenics, Raises Price Target to $4
Barclays analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Overweight and raises the price target from $3 to $4.
03-10 22:17
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Vir Biotechnology (NASDAQ:VIR) shares moved upwards by 65.0% to $12.26...
02-24 20:05
Why Is MacroGenics Stock Sinking Tuesday?
MacroGenics sees stock decline after FDA places partial clinical hold on Phase 2 LINNET study due to safety concerns.
02-24 19:16
美股牛股 | Medline上市首日大涨超41%，最新市值超322亿美元，为今年最大IPO；Udemy涨超12%
Medline上市首日大涨超41%，最新市值超322亿美元，为今年最大IPO；Udemy涨超12%，与Coursera合并以扩大全球AI教育市场份额>>
2025-12-18 19:07
